Skip to main content
GENFIT logo

GENFIT — Investor Relations & Filings

Ticker · GNFT ISIN · FR0004163111 LEI · 969500XPWN2DMZQA5X73 PA Professional, scientific and technical activities
Open in API
Filings indexed 681 across all filing types
Latest filing 2014-12-01 Regulatory Filings
Country FR France
Listing PA GNFT

About GENFIT

https://www.genfit.com

GENFIT is a biopharmaceutical company dedicated to developing therapeutic and diagnostic solutions for patients with rare and severe liver diseases characterized by high unmet medical needs. The company's primary focus is on Acute-on-Chronic Liver Failure (ACLF) and its associated conditions, such as acute decompensation (AD) and hepatic encephalopathy (HE). Leveraging a scientific heritage of over two decades, GENFIT is a pioneer in liver disease research and development, aiming to improve the lives of patients with these life-threatening conditions.

Recent filings

Filing Released Lang Actions
PDF Version
Regulatory Filings Classification · 95% confidence The document is explicitly titled as a "Press release" from 2014. It announces a specific operational update regarding a clinical trial (GOLDEN-505) completion and its statistical implications. This type of announcement, which provides key operational or preliminary results outside of a full quarterly/annual report, typically falls under an Earnings Release (ER) if it contains financial highlights, or more generally, a Regulatory Filing (RNS) if it's a general operational update required for market transparency. Since it is a press release announcing a milestone and not a full financial report (like 10-K or IR), and it doesn't fit the specific definitions for DIV, CAP, MANG, etc., the most appropriate general category for a timely, non-financial-statement-focused announcement is RNS (Regulatory Filings/General Announcement). However, given the content is a significant operational update that impacts future earnings potential, it strongly resembles an Earnings Release (ER) which often includes operational milestones alongside financial figures, even if financial figures are sparse. Since this is a press release announcing a trial milestone and not a formal earnings report, RNS is the safest general classification, but ER is often used for trial updates that affect outlook. Given the lack of explicit financial results (like revenue, EPS), RNS is the better fit as a general regulatory/market announcement.
2014-12-01 English
PDF Version
Regulatory Filings Classification · 95% confidence The document is explicitly titled '2014 Press release' and announces that GENFIT was 'honored at the 'INVESTOR AWARDS 2014''. It contains quotes from the CEO regarding shareholder communication and provides general company information, contacts, and disclaimers typical of a public announcement. This is not a formal regulatory filing like a 10-K, an earnings release (ER), or a detailed financial report (IR). It is a general corporate announcement regarding an award received, which fits best under the general 'Regulatory Filings' (RNS) category as a miscellaneous, non-standard announcement, or potentially a very specific type of Investor Relations communication. Given the options, RNS serves as the best general catch-all for press releases that don't fit the specific financial/governance/capital event codes. It is not a Call Transcript (CT), Earnings Release (ER), or a formal report (10-K, IR).
2014-11-28 English
Version PDF
Earnings Release Classification · 99% confidence The document is titled 'Communiqué de presse' (Press Release) and announces that GENFIT was distinguished at the 'INVESTOR AWARDS 2014'. It details an award received and includes quotes from the Chairman of the Management Board regarding communication efforts. This type of announcement, which is a general corporate update or news item not fitting into specific financial reporting categories (like 10-K, ER, or IR), is best classified as a general Regulatory Filing or Announcement. Since it is a press release announcing an award and general corporate news, and it doesn't fit the specific definitions for dividend, management change, or financing, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements. FY 2014
2014-11-28 French
Version PDF
Regulatory Filings Classification · 95% confidence The document is titled "Communiqué de presse" (Press Release) and announces the company's upcoming presence at three investor conferences (Credit Suisse Healthcare Conference, Biotech Portzamparc Seminar, Deutsche Bank BioFEST). It details the dates and locations for management meetings and presentations. This type of announcement, which informs investors about future participation in industry events, is typically classified as an Investor Presentation (IP) if it were the presentation itself, or more accurately, a general announcement regarding investor relations activities. Since the document is a short press release announcing future events rather than a detailed financial report (10-K, IR, ER) or a formal regulatory filing, and it focuses on investor engagement, it fits best under the general category for investor-related communications that aren't formal reports or specific transaction notices. However, given the options, the content is primarily about informing investors about upcoming opportunities to engage with management at conferences. This is often bundled with Investor Presentation materials or treated as a general regulatory announcement. Since it is a press release announcing participation in investor events, and not a formal financial report, the most fitting category among the specific options is difficult. It is not a Call Transcript (CT), Earnings Release (ER), or a formal report (10-K, IR). It is an announcement about investor engagement. Given the options, and recognizing this is a standard corporate communication about investor outreach, it is closest to an Investor Presentation (IP) in spirit, or potentially a Regulatory Filing (RNS) if it were purely administrative. Since it is a specific announcement about investor meetings, and not a formal report, I will lean towards RNS as the most appropriate general regulatory announcement fallback, as it doesn't fit the specific definitions of ER, IR, or IP (which usually implies the presentation slides themselves). Re-evaluating the definitions: It is not a DIV, DIRS, MANG, or CAP. It is a press release announcing future investor engagement. This is a common type of announcement. If the company were issuing slides, it would be IP. Since it is just the announcement of attendance, RNS (Regulatory Filings/General Announcement) is the safest fallback, although some systems might categorize this as a specific Investor Relations announcement not explicitly listed. Given the context of informing the market about management availability at conferences, RNS is the most appropriate catch-all for non-standard, non-financial report announcements.
2014-11-07 French
PDF Version
Investor Presentation Classification · 95% confidence The document is explicitly titled as a "Press release" from 2014. The content details the company's management participation schedule for three upcoming investor conferences (Credit Suisse Healthcare Conference, Portzamparc Biotech Conference, and Deutsche Bank BioFEST). This type of announcement, informing the public about management's schedule for meetings with investors and analysts at industry events, is best classified as a general communication to investors regarding corporate activities, which often falls under Investor Presentation (IP) if it were a deck, or more generally, a Regulatory Filing (RNS) if it's a standard press release not fitting other specific categories. However, since the core purpose is to announce management's engagement schedule with investors, it is a form of investor relations communication. Given the options, it is not a formal financial report (10-K, IR, ER), a management change (MANG), or a specific voting/dividend notice. It is a general announcement about corporate outreach. Since it is a press release announcing future events rather than a specific regulatory filing type like DIRS or DIV, and it is not a transcript (CT) or a formal presentation (IP), the most appropriate general category for a non-standard, informational press release is Regulatory Filings (RNS), as it is a broad announcement. Revisiting the definitions: It is not an Investor Presentation (IP) as it's just a schedule, not the presentation itself. It is a press release announcing management's schedule for investor meetings. This is a common type of corporate disclosure. Given the available codes, RNS (Regulatory Filings - general fallback) is the most suitable category for a standard press release announcing participation in investor conferences when a more specific category like 'IP' (Investor Presentation) or 'ER' (Earnings Release) does not apply.
2014-11-07 English
Version PDF
Earnings Release Classification · 98% confidence The document is titled 'GENFIT ANNONCE SON CHIFFRE D'AFFAIRES ET SA TRESORERIE AU 30 SEPTEMBRE 2014' (GENFIT ANNOUNCES ITS REVENUE AND CASH POSITION AS OF SEPTEMBER 30, 2014) and is explicitly labeled as a 'Communiqué de presse' (Press Release). It provides key financial highlights (revenue and cash balance) for a specific interim period (9 months ended September 30, 2014). This format, focusing on preliminary, non-audited results announced via press release, aligns perfectly with the definition of an Earnings Release (ER), which covers initial announcements of periodical financial results (key highlights only). It is too brief and focused on highlights to be a full Interim Report (IR) or Annual Report (10-K). 9M 2014
2014-11-04 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.